Biotechnology ResearchOslo, Norway51-200 Employees
We are a leading technology platform that unlocks unlimited possibilities for the future of medicine through our intelligent modular design and tailored hyper targeting.
| Nykode Therapeutics Email Formats | Percentage |
| FLast@vaccibody.com | 55% |
| F.Last@vaccibody.com | 14% |
| FMLast@vaccibody.com | 7% |
| FL@vaccibody.com | 6% |
| First.Last@vaccibody.com | 5% |
| FMiddleLast@vaccibody.com | 4% |
| FirstLast@vaccibody.com | 2% |
| First.L@vaccibody.com | 2% |
| First.Middle.Last@vaccibody.com | 1% |
| FirstLas@vaccibody.com | 1% |
| LFirst@vaccibody.com | 1% |
| First_Last@vaccibody.com | 1% |
| LastFir@vaccibody.com | 1% |
| FLast@nykode.com | 67% |
| FLast@nykode.com | 16% |
| FLast@nykode.com | 17% |
Check if your email matches the formats in our database with our efficient email format checker tool.
| Matching Format | Percentage |
| FLast@vaccibody.com | 55% |
| F.Last@vaccibody.com | 14% |
| FMLast@vaccibody.com | 7% |
| FL@vaccibody.com | 6% |
| First.Last@vaccibody.com | 5% |
| FMiddleLast@vaccibody.com | 4% |
| FirstLast@vaccibody.com | 2% |
| First.L@vaccibody.com | 2% |
| First.Middle.Last@vaccibody.com | 1% |
| FirstLas@vaccibody.com | 1% |
| LFirst@vaccibody.com | 1% |
| First_Last@vaccibody.com | 1% |
| LastFir@vaccibody.com | 1% |
| FLast@nykode.com | 67% |
| FLast@nykode.com | 16% |
| FLast@nykode.com | 17% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com